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The risk of acquisition of resistance to chemotherapy remains a major hurdle in the 
management of various types of cancer patients. Several cellular and non-cellular 
mechanisms are involved in developing both intrinsic and acquired resistance in 
cancer cells toward chemotherapy. This review covers the various multidrug 
resistance (MDR) mechanisms observed in cancer cells as well as the various 
strategies developed to overcome these MDR mechanisms. Extensive studies have 
been conducted during the last several decades to enhance the efficacy of 
chemotherapy by suppressing or evading these MDR mechanisms including the use 
of new anticancer drugs that could escape from the efflux reaction, MDR modulators 
or chemosensitizers, multifunctional nanocarriers, and RNA interference (RNAi) 
therapy. 
Introduction: 
 The risk of tumors acquiring resistance to chemotherapy (multidrug resistance) 
remains a major hurdle to the successful treatment of various types of cancers 
including blood, breast, ovarian, lung, and lower gastrointestinal tract cancers. 
Multidrug resistance (MDR) is a phenomenon in which cancer cells exhibit a cross-
resistant phenotype against multiple unrelated drugs that are structurally and/or 
functionally different and may also have different molecular targets. 
Methods and Results: 
 Hypoxia in cancer might lead to multidrug resistance via different cellular pathways 
such as lost sensitivity to p53-mediated apoptosis, and enhanced P-glycoprotein 
expression. Till now , the most widely studied MDR mechanisms are those 
associated with drug efflux mechanisms involving ATP-binding cassette (ABC) 
membrane transporters . 
Conclusions: 
Targeted nanocarriers present a powerful and versatile platform to overcome this life 
threatening disease. 
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